Innovative Drug Targets for ALS: A New Hope

This chapter highlights Insitro's achievement in securing $25 million from Bristol-Myers Squibb for a novel ALS drug target. The discussion emphasizes the potential of this target to reverse ALS pathology and the hope for impactful treatments for patients.